Abstract
A new method to slow myopia progression utilises Diffusion Optics Technology™ (DOT) spectacle lenses. The proposed mechanism of action for the DOT lenses is to modulate contrast across the photoreceptor cells, leading to an altered activity of the ON and OFF pathways and slowing the progression of axial elongation. This approach is different to the current optical approaches that utilise optical defocus to reduce hyperopic defocus at the peripheral retina while central vision is fully corrected to slow myopia. Initial clinical studies with the DOT lenses have demonstrated promising results with a reduction in progression of myopia. This overview summarises the current knowledge on myopia risk factors, the evidence for involvement of contrast signalling pathways in refractive error development, and the theories and mechanisms behind DOT lens technology. It also considers the role for contrast and the paradoxical observations given the established paradigm of form deprivation in animal models.
Original language | English |
---|---|
Article number | 100672 |
Number of pages | 9 |
Journal | Ophthalmology Science |
Volume | 5 |
Issue number | 4 |
Early online date | 9 Dec 2024 |
DOIs | |
Publication status | Published - Jul 2025 |
Bibliographical note
Copyright © 2024 by the American Academy of Ophthalmologyé.This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords
- Contrast modulation
- Diffusion optics
- Myopia control
- ON–OFF pathways